Mechanisms underlying the endothelium-independent relaxation induced by anqiotensin II in rat aorta

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 2, 2005, Pages 136-143

  Fukada, Sandra Y ^a   Tirapelli, Carlos R ^a   De Godoy, Márcio A F ^a   De Oliveira, Ana M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; AT2receptor; Bradykinin; Rat aorta; Vasorelaxation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINOPYRIDINE; A 779; AMILORIDE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; APAMIN; BRADYKININ; BRADYKININ B2 RECEPTOR; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; CYCLIC GMP; EDETIC ACID; GLIBENCLAMIDE; ICATIBANT; INDOMETACIN; LOSARTAN POTASSIUM; METALLOPROTEINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; SODIUM PROTON EXCHANGE PROTEIN; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BRADYKININ; ENDOTHELIUM, VASCULAR; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, BRADYKININ B2; SODIUM-HYDROGEN ANTIPORTER; VASOCONSTRICTOR AGENTS;

EID: 12844284536     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000151929.34896.c3     Document Type: Article

References (42)

1. de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415-472.
2. Bumpus FM, Catt KJ, Chiu AT, et al. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension. 1991;17:720-721.
3. 2 receptor: searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci. 1995;16:223-225.
4. Toda N, Miyazaki M. Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol. 1981;240:H247-H254.
5. Yamaguchi K, Nishimura H. Angiotensin II-induced relaxation of fowl aorta. Am J Physiol. 1988;255:R591-R599.
6. Tsutsumi Y, Matsubara H, Masaki H, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925-935.
7. Katada J, Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol. 2002;136:484-491.
8. Israel A, Cierco M, Sosa B. Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins. Eur J Pharmacol. 2000;394:103-108.
9. Cote F, Laflamme L, Payet MD, et al. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr Res. 1998;24:403-407.
10. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264-269.
11. Siragy HM, Inagami T, Ichiki T, et al. Sustained hypersensitivity to angiotensin H and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA. 1999;96:6506-6510.
12. Dimitropoulou C, White RE, Fuchs L, et al. Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels. Hypertension. 2001;37:301-307.
13. Haberl RL, Anneser F, Villringer A, et al. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am J Physiol. 1990;258:H1840-H1846.
14. Kimura T, Toda N, Noda Y, et al. Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries. J Cardiovasc Pharmacol. 2001;37:585-595.
15. 1 receptor antagonist. J Biol Chem. 2001;276:39721-39726.
16. de Gasparo M. Angiotensin II and nitric oxide interaction. Heart Fail Rev. 2002;7:347-358.
17. de Godoy MA, de Oliveira AM. Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle. J Pharmacol Exp Ther. 2002;303:333-339.
18. 2 receptor. Trends Endocrinol Metab. 2000;11:1-6.
19. Yayama K, Horii M, Hiyoshi H, et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther. 2004;308:736-743.
20. 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension. 1999;33:366-372.
21. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA. 1995; 92:10663-10667.
22. 2 receptor expression and signaling. Physiol Genomics. 2000;2:13-20.
23. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288:373-376.
24. le Tran Y, Forster C. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol. 1997;30:676-682.
25. Lalu K, Lampelo S, Vanha-Perttula T. Characterization of three amino-peptidases purified from maternal serum. Biochim Biophys Acta. 1986; 873:190-197.
26. Haberl RL, Decker PJ, Einhaupl KM. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res. 1991;68:1621-1627.
27. Rattan S, Fan YP, Puri RN. Comparison of angiotensin II (Ang II) effects in the internal anal sphincter (IAS) and lower esophageal sphincter smooth muscles. Life Sci. 2002;70:2147-2164.
28. de Godoy MA, Accorsi-Mendonca D, de Oliveira AM. Inhibitory effects of atropine and hexamethonium on the angiotensin II-induced contractions of rat anococcygeus smooth muscles. Naunyn Schmiedebergs Arch Pharmacol. 2003;367:176-182.
29. Viswanathan M, Tsutsumi K, Correa FM, et al. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun. 1991;179:1361-1367.
30. 1 receptors in neointima of rat aorta. J Clin Invest. 1992;90:1707-1712.
31. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
32. Kubaszewski E, Peters A, McClain S, et al. Light-activated release of nitric oxide from vascular smooth muscle of normotensive and hypertensive rats. Biochem Biophys Res Commun. 1994;200:213-218.
33. Cherry PD, Furchgott RF, Zawadzki JV, et al. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA. 1982;79:2106-2110.
34. Forstermann U, Hertting G, Neufang B. The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol. 1986;87:521-532.
35. Ritter JM, Doktor HS, Cragoe EJ Jr. Actions of bradykinin and related peptides on rabbit coeliac artery rings. Br J Pharmacol. 1989;96:23-28.
36. Thapaliya S, Matsuyama H, Takewaki T. Bradykinin causes endothelium-independent hyperpolarisation and neuromodulation by prostanoid synthesis in hamster mesenteric artery. Eur J Pharmacol. 2000;408:313-321.
37. 1 receptor blockade. J Cardiovasc Pharmacol. 2002;39:478-487.
38. + channels in photorelaxation of vascular smooth muscle. Eur J Pharmacol. 1998;347:215-221.
39. Kang J, Sumners C, Posner P. Angiotensin II type 2 receptor-modulated changes in potassium currents in cultured neurons. Am J Physiol. 1993; 265:C607-C616.
40. + currents involves an inhibitory GTP binding protein. Am J Physiol. 1994;267:C1389-C1397.
41. 2 receptors in modulating coronary microvascular function. Circ Res. 2003;92:322-329.
42. 1 receptor antagonists. Hypertension. 1999;33:850-855.